On Monday, Lipella Pharmaceuticals Inc (NASDAQ: LIPO) opened lower -12.80% from the last session, before settling in for the closing price of $0.39. Price fluctuations for LIPO have ranged from $0.32 to $1.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 20.14% over the last five years. Company’s average yearly earnings per share was noted 28.57% at the time writing. With a float of $5.16 million, this company’s outstanding shares have now reached $6.05 million.
The firm has a total of 7 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.65%, operating margin of -396.88%, and the pretax margin is -391.01%.
Lipella Pharmaceuticals Inc (LIPO) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Lipella Pharmaceuticals Inc is 35.49%, while institutional ownership is 7.87%. The most recent insider transaction that took place on May 14 ’24, was worth 7,590. In this transaction insider of this company bought 10,000 shares at a rate of $0.76, taking the stock ownership to the 898,849 shares. Before that another transaction happened on Mar 18 ’24, when Company’s insider below. bought 30,000 for $0.79, making the entire transaction worth $23,649. This insider now owns 863,849 shares in total.
Lipella Pharmaceuticals Inc (LIPO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 28.57% per share during the next fiscal year.
Lipella Pharmaceuticals Inc (NASDAQ: LIPO) Trading Performance Indicators
Check out the current performance indicators for Lipella Pharmaceuticals Inc (LIPO). In the past quarter, the stock posted a quick ratio of 4.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63 and is forecasted to reach -0.40 in one year’s time.
Technical Analysis of Lipella Pharmaceuticals Inc (LIPO)
Analysing the last 5-days average volume posted by the [Lipella Pharmaceuticals Inc, LIPO], we can find that recorded value of 0.28 million was lower than the volume posted last year of 1.33 million. As of the previous 9 days, the stock’s Stochastic %D was 18.75%. Additionally, its Average True Range was 0.04.
During the past 100 days, Lipella Pharmaceuticals Inc’s (LIPO) raw stochastic average was set at 1.36%, which indicates a significant decrease from 4.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.76% in the past 14 days, which was lower than the 169.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4277, while its 200-day Moving Average is $0.6392. Now, the first resistance to watch is $0.3758. This is followed by the second major resistance level at $0.4123. The third major resistance level sits at $0.4345. If the price goes on to break the first support level at $0.3171, it is likely to go to the next support level at $0.2949. Should the price break the second support level, the third support level stands at $0.2584.
Lipella Pharmaceuticals Inc (NASDAQ: LIPO) Key Stats
There are currently 8,005K shares outstanding in the company with a market cap of 2.74 million. Presently, the company’s annual sales total 450 K according to its annual income of -4,620 K. Last quarter, the company’s sales amounted to 140 K and its income totaled -940 K.
